Purification and characterization of active recombinant human napsin A. 2000

V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
F. Hoffmann-La Roche Ltd, Pharma Division, Preclinical Research, Basel, Switzerland.

Recombinant human napsin A expressed in human embryonic kidney 293 cells was purified to homogeneity by a single-step procedure using part of napsin A propeptide as affinity ligand. N-Terminal amino-acid sequencing of the purified enzyme identified the mature form of napsin A. Treatment of purified napsin A with endoglycosidases F and H resulted in a decrease in its molecular mass from 39 kDa to approximately 37 kDa, confirming that napsin A is glycosylated. The kinetic properties were analyzed by using two fluorogenic synthetic substrates K(Dabsyl)-TSLLMAAPQ-Lucifer yellow (DS1) and K(Dabsyl)-TSVLMAAPQ-Lucifer yellow (DS3). The Km values obtained were 1.7 microM and 6.2 microM, respectively. A substrate-specificity study using a napsin A-targeted peptide library confirmed the preference of napsin A for hydrophobic residues at positions P1 and P1'. Adjacent positions, P2-P4 and P2'-P4', appeared less restricted in distribution of amino acids. A pH optimum between 4.0 and 5.5 at room temperature was determined. The purified enzyme was fully active for more than 10 h at pH 5.0 and 6.0, while a half-life of 4 h was determined at pH 7.0 and 37 degrees C.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004795 Enzyme Stability The extent to which an enzyme retains its structural conformation or its activity when subjected to storage, isolation, and purification or various other physical or chemical manipulations, including proteolytic enzymes and heat. Enzyme Stabilities,Stabilities, Enzyme,Stability, Enzyme
D006031 Glycosylation The synthetic chemistry reaction or enzymatic reaction of adding carbohydrate or glycosyl groups. GLYCOSYLTRANSFERASES carry out the enzymatic glycosylation reactions. The spontaneous, non-enzymatic attachment of reducing sugars to free amino groups in proteins, lipids, or nucleic acids is called GLYCATION (see MAILLARD REACTION). Protein Glycosylation,Glycosylation, Protein
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein

Related Publications

V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
August 1990, Biochemical and biophysical research communications,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
April 2008, Chinese medical journal,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
June 2001, Biochimica et biophysica acta,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
February 1993, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
June 1998, Wei sheng wu xue bao = Acta microbiologica Sinica,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
June 2017, Protein expression and purification,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
January 1995, Advances in experimental medicine and biology,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
April 2009, Molecular and cellular endocrinology,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
April 2004, Journal of biochemistry,
V Schauer-Vukasinovic, and D Bur, and E Kitas, and D Schlatter, and G Rossé, and H W Lahm, and T Giller
June 1990, Biochimica et biophysica acta,
Copied contents to your clipboard!